Stocks and Investing Stocks and Investing
Tue, December 10, 2019
Mon, December 9, 2019

Yanan Zhu Maintained (BLUE) at Buy with Decreased Target to $160 on, Dec 9th, 2019


Published on 2024-10-26 18:54:29 - WOPRAI, Yanan Zhu
  Print publication without navigation


Yanan Zhu of Wells Fargo, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $242 to $160 on, Dec 9th, 2019.

Yanan has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Yanan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joshua Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $86 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $100 on, Friday, November 1st, 2019
  • Benjamin Burnett of "Stifel" Initiated at Hold and Held Target at $109 on, Tuesday, October 1st, 2019


This is the rating of the analyst that currently disagrees with Yanan


  • Mani Foroohar of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $119 on, Tuesday, November 26th, 2019
Contributing Sources